Ayala Pharmaceuticals
(NASDAQ) AYLA
Ayala Pharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$692.00K
Net Income (TTM)
$38.01M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
AYLA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ayala Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
21
CEO
Ken Berlin
Website
www.ayalapharma.comHeadquarters
Rehovot, 7670104, IL
AYLA Financials
Key Financial Metrics (TTM)
Gross Margin
13%
Operating Margin
-54%
Net Income Margin
-55%
Return on Equity
-2%
Return on Capital
13%
Return on Assets
-8%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$90.00K
Operating Income
$37.50M
EBITDA
$37.34M
Operating Cash Flow
$34.51M
Capital Expenditure
$2.00K
Free Cash Flow
$34.51M
Cash & ST Invst.
$2.41M
Total Debt
$1.75M
Ayala Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$105.00K
+104.4%
Gross Profit
$38.00K
+98.9%
Gross Margin
-36.19%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
35
N/A
Net Income
$9.59M
-12.8%
EBITDA
$17.70M
-55.6%
Quarterly Fundamentals
Net Cash
$657.00K
-98.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$1.75M
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-8.30%
N/A
Return on Invested Capital
12.69%
N/A
Free Cash Flow
$8.17M
-4.8%
Operating Cash Flow
$8.17M
-4.8%